Valuation : Grifols, S.A.

Market Cap 5.94B 6.88B 5.59B 5.09B 9.57B 653B 9.62B 66.03B 25.7B 332B 25.84B 25.28B 1,102B P/E 2026 *
12.6x
P/E 2027 * 9.67x
Enterprise Value 14.38B 16.67B 13.53B 12.33B 23.18B 1,582B 23.3B 160B 62.25B 805B 62.6B 61.25B 2,669B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.73x
Free-Float
79.65%
Yield 2026 *
2.77%
Yield 2027 * 3.03%
1 day-0.73%
1 week-2.00%
Current month+0.02%
1 month-2.25%
3 months+8.07%
6 months-6.57%
Current year-8.09%
1 week 9.75
Extreme 9.752
10.1
1 month 9.62
Extreme 9.622
10.32
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
12.87
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
22.64
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 58 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Chairman 76 2010-01-24
Director/Board Member 70 2000-04-12
Director/Board Member 62 2015-05-23
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/26 Free

Director

7,679 0.0018%
2/26/26 Free

Director

1,408 0.0005%
2/18/26 Others

Director

1,408 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%-2.00%-16.91%-22.54% 6.88B
+3.10%-1.17%+41.87%-0.94% 82.26B
+0.89%+0.82%-16.57%-35.23% 59.05B
+9.93%-2.87%+540.39%+37.06% 61.59B
+0.13%-4.10%-0.74%+34.87% 51.23B
-0.55%-1.67%+9.89%+165.91% 48.3B
-0.28%-2.14%+63.39%-19.14% 31.92B
+1.45%-3.63%+47.75%+93.24% 25.34B
+0.20%-7.29%-3.32%+195.07% 22.56B
-0.13%-1.29%+66.62%+112.33% 16.56B
Average +0.18%-2.28%+73.24%+56.06% 40.57B
Weighted average by Cap. +0.42%-2.63%+99.42%+43.83%

Financials

2026 *2027 *
Net sales 7.66B 8.87B 7.2B 6.56B 12.34B 842B 12.4B 85.13B 33.14B 428B 33.32B 32.6B 1,421B 8.13B 9.43B 7.65B 6.97B 13.11B 895B 13.18B 90.46B 35.21B 455B 35.41B 34.64B 1,510B
Net income 536M 621M 504M 459M 863M 58.93B 868M 5.96B 2.32B 29.98B 2.33B 2.28B 99.39B 699M 811M 658M 599M 1.13B 76.94B 1.13B 7.78B 3.03B 39.14B 3.04B 2.98B 130B
Net Debt 8.45B 9.79B 7.94B 7.24B 13.61B 929B 13.68B 93.91B 36.55B 473B 36.76B 35.96B 1,567B 8.1B 9.39B 7.62B 6.94B 13.06B 892B 13.13B 90.12B 35.08B 454B 35.27B 34.51B 1,504B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,258
Date Price Change Volume
26-09-02 9.844 -0.83% 455,912
26-09-01 €9.926 +0.96% 1,081,146
26-08-31 €9.832 -1.19% 962,512
26-08-28 €9.950 -1.04% 979,824
26-08-27 €10.06 +0.20% 764,067
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.926EUR
Average target price
14.76EUR
Spread / Average Target
+48.68%

Quarterly revenue - Rate of surprise